Alexia Carré

Alexia holds an Engineering degree in Biotechnology and a Master’s degree in High-Throughput Biotechnology from the University of Strasbourg, France. During her undergraduate studies, she explored the molecular and cellular interactions between neutrophils and tumor cells, with a particular focus on their role in tumor progression.

She went on to pursue a PhD in Immunology at the University of Paris Cité, where her research investigated how viral infection and inflammation influence the antigenic visibility of pancreatic beta cells in type 1 diabetes.

Following her PhD, Alexia joined Utrecht University as a postdoctoral researcher, studying the communication dynamics between immune and cancer cells using mass spectrometry-based approaches.

She is currently a postdoctoral researcher in the Pröbstel Lab at University Hospital Basel. Her work focuses on characterizing MOG antigenic display by B cells and analyzing T cell responses to MOG peptides, in the context of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).